- In recent commentary, FIGS, the healthcare apparel company known for stylish scrubs, has been flagged for relatively weak demand, a shrinking active customer base, declining earnings per share over several years, and constrained free cash flow margins that limit reinvestment options.
- This combination of softer customer metrics and thinner cash generation is drawing renewed investor attention to whether FIGS’ business model can consistently convert brand awareness into profitable, sustainable growth.
- We’ll now examine how concerns about weak demand and declining earnings performance might reshape FIGS’ previously optimistic investment narrative.
Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
FIGS Investment Narrative Recap
To own FIGS today, you have to believe its brand can translate social buzz and a focused healthcare niche into consistent, profitable demand, despite recent signs of softer customer activity and thinner free cash flow. The key near term catalyst is whether FIGS can stabilize active customer trends, while the biggest current risk is that weak demand and limited cash generation make it harder to fund product and international initiatives. The latest news directly heightens both of these concerns.
Against this backdrop, FIGS’ recent 2026 guidance for 10% to 12% net revenue growth, later raised to 14% to 16%, is particularly relevant. That outlook sits in tension with reports of relatively low demand and a shrinking active customer base, and it places more weight on upcoming quarters to show that revenue growth and earnings can hold up even as customer metrics and free cash flow margins come under pressure.
But beneath the upbeat guidance, one issue investors should be aware of is how fragile FIGS’ customer base may be if...
Read the full narrative on FIGS (it's free!)
FIGS' narrative projects $862.6 million revenue and $77.4 million earnings by 2029. This requires 9.0% yearly revenue growth and a $36.8 million earnings increase from $40.6 million today.
Uncover how FIGS' forecasts yield a $17.62 fair value, a 44% upside to its current price.
Exploring Other Perspectives
Some of the lowest ranked analysts were already cautious, expecting FIGS to reach about US$621.8 million in revenue and US$40.1 million in earnings by 2028, which contrasts sharply with the more optimistic view that international expansion and product innovation will steadily offset demand risks; this new weak demand news might push you to reconsider which side of that wide opinion range feels more realistic.
Explore 5 other fair value estimates on FIGS - why the stock might be worth as much as 80% more than the current price!
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your FIGS research is our analysis highlighting 3 key rewards that could impact your investment decision.
- Our free FIGS research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate FIGS' overall financial health at a glance.
Interested In Other Possibilities?
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
- Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.
- Outshine the giants: these 14 early-stage AI stocks could fund your retirement.
- Explore 29 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com